AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 179 filers reported holding AERIE PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.80 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $38,000 | -48.6% | 1,300 | -16.1% | 0.07% | -56.9% |
| Q1 2019 | $74,000 | +42.3% | 1,550 | +6.9% | 0.16% | +45.5% |
| Q4 2018 | $52,000 | -29.7% | 1,450 | +20.8% | 0.11% | +5.8% |
| Q3 2018 | $74,000 | -8.6% | 1,200 | 0.0% | 0.10% | -29.7% |
| Q2 2018 | $81,000 | +50.0% | 1,200 | +20.0% | 0.15% | +55.8% |
| Q1 2018 | $54,000 | +200.0% | 1,000 | +233.3% | 0.10% | +458.8% |
| Q4 2017 | $18,000 | +20.0% | 300 | 0.0% | 0.02% | +41.7% |
| Q3 2017 | $15,000 | -6.2% | 300 | 0.0% | 0.01% | +9.1% |
| Q2 2017 | $16,000 | +14.3% | 300 | 0.0% | 0.01% | 0.0% |
| Q1 2017 | $14,000 | -97.0% | 300 | -97.6% | 0.01% | -97.2% |
| Q3 2016 | $472,000 | – | 12,500 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LEVIN CAPITAL STRATEGIES, L.P. | 1,373,542 | $15,658,000 | 1.56% |
| DAFNA Capital Management LLC | 289,040 | $3,295,000 | 0.87% |
| Integral Health Asset Management, LLC | 250,000 | $2,850,000 | 0.82% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 193,266 | $2,203,000 | 0.80% |
| PFM Health Sciences, LP | 2,182,684 | $24,883,000 | 0.73% |
| DCF Advisers, LLC | 136,501 | $1,556,000 | 0.69% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,977,020 | $33,938,000 | 0.66% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $3,532,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 750,000 | $8,550,000 | 0.60% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,232,600 | $14,052,000 | 0.52% |